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Ageing is associated with reduced appetite and energy intakes. However, the mechanisms 
underlying this phenomenon are not fully understood. This systematic review and meta-
analysis quantified differences in circulating concentrations of appetite-related hormones 
between healthy older and younger adults. 
Six databases were searched through 12th June 2018 for studies that compared appetite-related 
hormone concentrations between older and younger adults. Data were pooled using random-
effects meta-analysis and are presented as standardised mean difference (Hedges’ g) with 95% 
confidence intervals (95% CI). 
Thirty five studies were included involving 710 older adults (mean±SD; age: 73±5 years) and 
713 younger adults (age: 28±7 years). Compared with younger adults, older adults exhibited 
higher fasted and postprandial concentrations of the anorectic hormones cholecystokinin 
(Fasted: SMD 0.41 (95%CI 0.24, 0.57); p<0.001. Postprandial: SMD 0.41 (0.20, 0.62); 
p<0.001), leptin (Fasted: SMD 1.23 (0.15, 2.30); p=0.025. Postprandial: SMD 0.62 (0.23, 
1.01); p=0.002) and insulin (Fasted: SMD 0.24 (-0.02, 0.50); p=0.073. Postprandial: SMD 0.16 
(0.01, 0.32); p=0.043). Higher postprandial concentrations of peptide-YY were also observed 
in older adults compared with younger adults (SMD 0.31 (-0.03, 0.65); p=0.075). Compared 
with younger adults, older adults had lower energy intakes (SMD -0.98 (-1.74, -0.22); 
p=0.011), and lower hunger perceptions in the fasted (SMD -1.00 (-1.54, -0.46); p<0.001) and 
postprandial state (SMD -0.31, (-0.64, 0.02); p=0.064).  
Higher circulating concentrations of insulin, leptin, cholecystokinin and peptide-YY accord 
with reduced appetite and energy intakes in healthy older adults. Interventions to reduce 
circulating levels of these hormones may be beneficial for combatting the anorexia of ageing.  





Currently 962 million people worldwide are over the age of 60 years [1] and it is predicted that 
22% of the global population will be 60 years and older by 2050 [2]. A high proportion of 
health care is spent on older adults and this is set to increase given the projected rise in this 
population. Therefore, improving health in older adults is a crucial public health priority. 
The “anorexia of ageing” describes a reduction in appetite and energy intake in older adults. 
Current observations suggest that this phenomenon has a prevalence of 15-30% in 
independently-living older adults, with higher incidence occurring in hospital and nursing 
home settings [3]. The anorexia of ageing represents an independent risk factor for frailty, 
incident disability, morbidity and mortality [4,5,3]. Consequently, developing a better 
understanding of the mechanisms underlying the anorexia of ageing is important in designing 
interventions to prevent further deterioration in quality of life. 
Appetite is regulated physiologically by the neuroendocrine system [6], with multiple 
hormones implicated as mediators of hunger and satiety. Several hormones have been 
identified to exert appetite-supressing effects, including peptide YY (PYY), glucagon-like-
peptide-1 (GLP-1), oxytomodulin, pancreatic polypeptide (PP), cholecystokinin (CCK), gastric 
inhibitory peptide (GIP), insulin and leptin. Alternatively, ghrelin represents the only 
peripheral peptide known to exert an orexigenic effect [7,6]. Current research suggests that 
changes in appetite-related hormones may mediate the reductions in appetite and energy intake 
observed in older adults. However, conclusions are yet to be drawn due to inconsistent findings 
between studies, likely due to differences in methodologies and the hormones measured. For 
example, results from Giezenaar et al. [8] demonstrated higher plasma concentrations of CCK 
in older adults compared with younger adults, however, these concentrations did not differ 




A systematic evaluation of the literature is required to gain a clear understanding of which 
hormones exhibit altered concentrations between older and younger adults, as well as the 
direction and size of any effects. Thus, the purpose of this research was to provide a systematic 
review and meta-analysis of studies which compared circulating appetite-related hormone 
concentrations between metabolically-healthy older and younger adults in the fasted and/or 
postprandial state, with no known co-morbidities or pre-existing medical conditions. 
Comparisons of appetite perceptions and energy intake between the groups were also included 
where available. Understanding these effects contributes to the identification of potential 
mechanistic targets for future interventions to reduce the anorexia of ageing.  
Methods  
This systematic review and meta-analysis was performed in accordance with the PRISMA 
(Preferred Reporting Items for Systematic Review and Meta-analyses) guidelines [10] and was 
prospectively registered with the PROSPERO database (CRD42017083747).  
Literature Search 
PubMed and The Cochrane Library as well as MEDLINE, SPORTDiscus, PsycINFO and 
CINAHL, via EBSCOhost, were searched in December 2017, with an updated search on 12th 
June 2018. These databases were used to provide a thorough approach for searches to obtain 
the maximum number of relevant studies, including relevant data from studies in which 
exercise or psychological interventions were implemented. Keyword searches were based on 
the population (i.e., older adults) in combination with appetite-related hormones, and appetite 
perceptions and/or energy intake. The specific keywords and the full search strategy can be 
found in supplementary material 1. The search strategy provided a total of 328 combinations. 




abstract or partial data were published, then the author was contacted for the full data set. No 
language or date of publication restrictions were applied during the searches. 
Inclusion Criteria  
For inclusion, studies were required to meet the following criteria; participants in the study 
were not noted to be smokers, pregnant, or have a history of diabetes, gastrointestinal, 
inflammatory, metabolic, cardiovascular, neurological or psychological disease(s). Studies 
were excluded if there was evidence to show the implementation of a diet to induce energy 
imbalance, the administration of a supplement or taking medication as this is shown to affect 
appetite. Studies which investigated participants under the age of 18 were excluded. Studies 
were included if they were published in peer-review journals, or were available as published 
conference proceedings, theses or dissertations to minimise the effect of any potential 
publication bias. 
All studies were required to contain at least one of the following measures of circulating 
appetite-related hormone concentrations; leptin, acylated ghrelin, total ghrelin, oxyntomodulin, 
PYY, GLP-1, PP, GIP, CCK and/or insulin, in distinct groups of older and younger adults 
within the same study. Any postprandial comparisons of appetite-related hormone 
concentrations where <125kJ was provided during feeding were excluded from the analysis. 
Studies which involved the infusion of a nutrient as the feeding intervention were included, 
however studies involving the infusion of pharmacological products were excluded. In addition 
to these outcomes, appetite perceptions and/or energy intake data were extracted if provided in 
the included studies. 
Two researchers (KJ and OS) independently assessed titles and abstracts of studies for 
inclusion and later compared notes to reach a mutual consensus. Researchers were not blinded 




extraction had neither a clinically nor a statistically significant effect on the summary outcome 
[11]. Disagreements about the eligibility of any particular studies were resolved by a third 
reviewer (KD).  Potential studies that could be included based on their title or abstract were 
retrieved in full-text and reviewed against the inclusion/exclusion criteria independently by 
two researchers (KJ and OS) with a third researcher (KD) used to settle any disputes. In total 
35 studies met the inclusion criteria and were included in this meta-analysis (see flow chart in 
supplementary figure 1). For a variable to be included in the meta-analysis, a minimum of three 
studies measuring the respective variable were required to meet the inclusion criteria. 
Data Abstraction 
Data were extracted independently by two separate researchers (KJ and OS) into a standardised 
spreadsheet which included (i) characteristics of articles valid for review; (ii) the critical 
appraisal tool to assess the quality of cross-sectional studies (AXIS) (iii) outcome data suitable 
for successive analysis based on mean, SD and sample size. Researchers were not blinded to 
articles during this process, however risk of bias can be effectively conducted under blinded 
conditions [12]. Additional data were collected for study design, participant characteristics, the 
duration of observations and number of blood samples taken, hormone analytical method, as 
well as the assessment method of energy intake. 
Where values were only presented in figure form authors were contacted to provide the full 
data set. If the dataset could not be retrieved (n = 17) the figure was digitised using graph 
digitiser software (DigitizeIt, Germany) and the means and SD/SEM were measured manually 
at the pixel level to the scale provided on the figure. Digitizeit has been shown to provide valid 
and reliable results which provide good agreement with raw data values[13]. If area under the 
curve values were reported rather than the mean values, the mean values were calculated by 




Study Appraisal and Quality Assessment 
The critical appraisal tool to assess the quality of cross-sectional studies (AXIS) [14] was 
independently assessed by two reviewers (KJ and OS). Each included study was systematically 
evaluated against a 17-item checklist to judge study quality and the possibility of bias. 
Reviewers answered “yes” or “no” to each question within the checklist. When insufficient 
detail was reported the reviewers answered the question with “do not know”. Disagreements 
were initially resolved via discussion between two independent reviewers (KJ and OS) 
however a third reviewer (KD) was consulted for any necessary dispute resolution. Due to the 
cross-sectional nature of study designs within this meta-analysis, questions 7, 13 and 14 were 
removed in regards to addressing non-responders. Studies were not excluded based on the 
results of the quality assessment, however for transparency the quality of included studies has 
been presented in supplementary table 26.  
Statistical Analysis  
Missing standard deviations were calculated from standard errors or confidence intervals (CI). 
Outcome measures were converted into the standardised mean difference (SMD) and expressed 
as Hedges’ g with 95% CI which were used as the summary statistic. Correction using Hedges’ 
g is believed to yield an unbiased estimate of effect size [15].  The SMD represents the size of 
the difference between groups relative to the variability observed in the groups. A random-
effects meta-analysis was performed by KJ and KD using Comprehensive Meta-Analysis 
Software (version 3, Biostat, Englewood, NJ, USA). A random effects model was employed 
for all analyses based on the assumption that heterogeneity would exist between included 
studies due to the variability in study designs [16].The inputted data included sample sizes and 
outcome measures with their respective standard deviations.  
Interpretation of SMD values was as follows:  <0.20 as trivial, 0.20-0.39 as small, 0.40-0.80 as 




were higher in older adults compared with younger adults. Heterogeneity between trials was 
assessed using the I-squared statistic, where 0-40% suggests heterogeneity might not be 
important, 30-60% may represent moderate heterogeneity, 50-90% may represent substantial 
heterogeneity and 75-100% represent substantial heterogeneity [18]. This measure of 
heterogeneity was complimented by also reporting the Tau-squared statistic and the Chi-
squared statistic. To examine whether any conclusions were dependent on a single study, 
sensitivity analyses were employed for each variable by repeating the analysis with each study 
omitted in turn. 
Where data were available, subgroup meta-analysis was performed for feeding method 
(infusion versus eating), hormone analytical method (RIA versus ELISA) and energy intake 
assessment method (researcher-measured versus self-reported). Each subgroup was required to 
have a minimum of three studies. 
Exploration of small study effects 
Small study effects were explored with funnel plots of SMD versus standard errors [19] and by 
quantifying Egger’s linear regression intercept. A large and statistically significant Egger’s 
statistic indicates the presence of small study effects.  
Results 
Overview 
Supplementary figure 1 outlines the flowchart of study selection. In total 35 studies met the 
inclusion criteria for the meta-analysis. All included studies had been published (or accepted 
for publication) in peer-review scientific journals at the time of inclusion (see supplementary 
material 2 for article references). Within the 35 studies, there were 31 fasted and 25 
postprandial comparisons that were included between older and younger adults. Comparisons 




table 2) responses to differentiate between findings during these two distinct periods of appetite 
regulation. Fasted comparisons represent single time points obtained after an overnight fast, 
whereas postprandial comparisons represent means of multiple time points after feeding.  
There were four studies that involved more than two age groups; consequently, the youngest 
and oldest age groups were extracted for these studies. Out of the 35 studies which assessed 
circulating appetite-related hormone concentrations, 11 compared energy intake between older 
and younger adults (supplementary table 3). One study obtained energy intake by the 24-hour 
recall method, six studies by ad libitum meals and four through food diaries lasting three to 
five days. All studies which reported postprandial comparisons provided standardised meals or 
infusions to participants with an energy content of 502-4064 kJ (mean: 2454 kJ) and had 
hormone observation periods of 0.5 - 24 hours (mean: 4.41 hours). All studies involving 
postprandial comparisons provided mixed macronutrient meals, with 19 studies providing it in 
solid form, six studies involving the infusion of a nutrient, two studies providing it in liquid 
form and one study comparing both liquid and solid form. Three studies manipulated the 
macronutrient composition of the mixed meals to identify if this dictated postprandial 
outcomes. If a study contained more than one postprandial comparison for each age group, then 
the results were combined with the study being the unit for analysis. The effects of 
macronutrient manipulation were conflicting between studies, therefore, it is difficult to draw 
conclusions on the effects of macronutrient distribution on differences in appetite-related 
hormone concentrations between older and younger adults.  
Hunger was assessed alongside appetite-related hormone concentrations in 13 out of the 35 
studies, with seven studies evaluating both fasted and postprandial responses, five studies 
reporting only fasted responses and one study only presenting postprandial hunger perceptions 





A total of 713 younger adults and 710 older adults were included in this meta-analysis. Gender 
was reported in 31 out of 35 studies (532 men and 573 women; 48.1% men). Mean age ranged 
from 19 to 50 (mean: 28) years for younger adults. For older adults all studies ranged from 65 
to 85 (mean: 73) years. Mean BMI was reported in 25 out of 35 studies and ranged from 21.2 
to 28.1 (mean: 23.6) kg.m-2 for younger adults and 20.5 to 26.9 (mean: 24.8) kg.m-2 for older 
adults, therefore falling in the healthy weight category for both groups.  
 
Meta-analysis 
Individual study statistics and results for each outcome variable are summarised in 
supplementary tables 5 - 22.  
Standardised mean difference for acylated ghrelin concentrations 
Only one study which met the inclusion criteria included the measurement of circulating 
acylated ghrelin concentrations in the fasted state. Consequently, this could not be included in 
the meta-analysis.  
Postprandial acylated ghrelin concentrations were lower in older adults than younger adults, 
with a small difference between groups (SMD: -0.21, 95% CI: -0.76 to 0.35; n = 5; p = 0.466; 
supplementary figure 2). The degree of heterogeneity may be moderate between studies (I2= 
52.6%; Q = 8.4, τ2 = 0.208, df= 4).  
Standardised mean difference for total ghrelin concentrations 
There was little difference in fasted total ghrelin concentrations when comparing older adults 
with younger adults (SMD: 0.13, 95% CI: -0.12 to 0.39; n = 6; p = 0.312; supplementary figure 
3a). The degree of heterogeneity was found to be low between studies (I2= 0.00%; Q = 5.0, τ2< 




There was little difference in postprandial total ghrelin concentrations when comparing older 
adults with younger adults (SMD: 0.17, 95% CI: -0.06 to 0.40; n = 8; p = 0.146; supplementary 
figure 3b). The degree of heterogeneity was found to be low between studies (I2= 0.0%, Q = 
2.8, τ2< 0.0005, df= 7).  
Standardised mean difference for CCK concentrations 
Fasted CCK concentrations were higher in older adults than younger adults with a moderate 
difference between groups ( SMD: 0.41, 95% CI: 0.24 to 0.57; n = 9; p < 0.0005; figure 1a). 
The degree of heterogeneity was found to be low between studies (I2= 0.0%, Q = 7.6, 
τ2<0.0005, df= 8).  
Postprandial CCK concentrations were higher in older adults than younger adults with a 
moderate difference between groups (SMD: 0.41, 5% CI: 0.20 to 0.62, n = 8; p <0.0005; figure 
1b). The degree of heterogeneity was found to be low between studies (I 2= 7.2%, Q = 7.5, τ2= 
0.085, df= 7). 
 
INSERT FIGURE 1 NEAR HERE 
 
Standardised mean difference and moderator variables for GLP-1 concentrations 
There was little difference in fasted GLP-1 concentrations when comparing older adults with 
younger adults (SMD: -0.02, 95% CI: -0.44 to 0.40; n = 7; p = 0.942; supplementary figure 
4a). The degree of heterogeneity may be substantial between studies (I2= 75.8%; Q = 24.8, τ2= 
0.235 and df= 6).  
There was little difference in postprandial GLP-1 concentrations when comparing older adults 




4b). The degree of heterogeneity was found to be moderate between studies (I2= 48.7%, Q = 
11.7, τ2 = 0.078, df= 6).  
Standardised mean difference for leptin concentrations  
Fasted leptin concentrations were higher in older adults than younger adults with a large 
difference between groups (SMD: 1.23, 95% CI: 0.15 to 2.30; n = 9; p = 0.025; figure 2a). The 
degree of heterogeneity was found to be considerable between studies (I2= 96.7%, Q = 238.9 , 
τ2 = 2.545, df= 8).   
Postprandial leptin concentrations were higher in older adults than younger adults with a 
moderate difference between groups (SMD: 0.62, 95% CI: 0.23 to 1.01; n = 7; p = 0.002; figure 
2b). The degree of heterogeneity was found to be moderate between studies (I2= 51.5%, Q = 
12.4, τ2 = 0.138, df= 6).  
 
INSERT FIGURE 2 NEAR HERE 
 
Standardised mean difference and moderator variables for insulin concentrations 
Fasted insulin concentrations were higher in older adults than younger adults with a small 
difference between groups (SMD: 0.24, 95% CI: -0.02 to 0.50; n = 19; p = 0.073; figure 3a) 
The degree of heterogeneity may be substantial between studies (I2= 74.3%, Q = 70.1, τ2 = 
0.225, df= 18). Subgroup analysis revealed no significant effect of the hormone analytical 
method on outcomes (p = 0.99; Table 1).  
There was a trivial but significant difference in postprandial insulin concentrations between 
younger and older adults (SMD: 0.16, 95% CI: 0.01 to 0.32, n = 17; p = 0.043; figure 3b).The 




df = 17).Subgroup analysis revealed no significant effect of the hormone analytical method or 
feeding method on outcomes (both p > 0.42; Table 1).  
 
INSERT FIGURE 3 NEAR HERE 
 
Standardised mean difference for PYY concentrations 
Fasted PYY concentrations were lower in older adults than younger adults with a small 
difference between groups (SMD: -0.35, 95% CI: -1.10 to 0.40, n = 4; p = 0.357; figure 4a). 
The degree of heterogeneity may be substantial between studies (I2= 77.7%, Q = 13.4, τ2 = 
0.445, df= 3).  
Postprandial PYY concentrations were higher in older adults than younger adults with a small 
difference between groups (SMD: 0.31, 95% CI: -0.03 to 0.65; n = 4; p = 0.075; figure 4b). 
The degree of heterogeneity was found to be low between studies (I2= 0.0%, Q = 2.0, 
τ2<0.0005, df= 3).  
 
INSERT FIGURE 4 NEAR HERE 
 
Standardised mean difference and moderator variables for GIP concentrations  
Fasted GIP concentrations were higher in older adults than younger adults with a small 
difference between groups (SMD: 0.16, 95% CI: -0.23 to 0.54, n = 4; p = 0.334; supplementary 
figure 5a). The degree of heterogeneity was found to be substantial between studies (I2= 63.8%, 




Postprandial GIP concentrations were higher in older adults than younger adults with a small 
difference between groups (SMD: 0.25, 95% CI: -0.19 to 0.70; n = 4; p = 0.263; supplementary 
figure 5b). The degree of heterogeneity was found to be substantial between studies (I2 = 68.3%, 
Q = 9.5, τ 2= 0.140, df = 3).  
Standardised mean difference and moderator variables for energy intake 
Energy intake was lower in older adults than younger adults with a large difference between 
groups (SMD: -0.98, 95% CI: -1.74 to -0.22; n = 11; p = 0.011; figure 5). The degree of 
heterogeneity is substantial between studies (I2 = 94.6%; Q = 186.1, τ2 = 1.455, df = 10).). 
Subgroup analysis revealed a difference in energy intake between assessment types (p = 0.015), 
with older adults only showing a significantly lower energy intake compared with younger 
adults when assessed via self-report methods (table 1).  
 
INSERT FIGURE 5 NEAR HERE 
 
Standardised mean difference for hunger score 
Fasted hunger scores were lower in older adults than younger adults with a moderate difference 
between groups (SMD: -1.00, 95% CI: -1.54 to -0.46; n = 12; p = 0.0003; figure 6a). The degree 
of heterogeneity may be substantial between studies (I2 = 76.1%; Q = 46.1, τ2 = 0.671, df = 11).  
Postprandial hunger scores were lower in older adults than younger adults with a small 
difference between groups (SMD: -0.31, 95% CI: -0.64 to 0.02; n = 8; p = 0.064; figure 6b). 
The degree of heterogeneity may be moderate between studies (I2 = 37.7%; Q = 11.2, τ2 = 





INSERT FIGURE 6 NEAR HERE 
 
 
INSERT TABLE 1 NEAR HERE 
Sensitivity Analysis  
Out of the 18 variables assessed in the meta-analysis, 11 variables revealed only minor 
changes when one study was omitted in turn from each analysis. The remaining seven 
variables revealed the removal of one or more comparison caused significant changes to the 
SMD (supplementary table 23-25).   
Egger’s Regression 
Five out of the 18 variables assessed in the meta-analysis demonstrated some evidence of 
small study effects after inspection of the funnel plot and Egger’s Regression Intercept (see 
supplementary tables 23-25). The remainder of studies provided little evidence of small study 
effects.  
Quality assessment  
The quality of studies appeared to vary. Most studies met more than 8 of the quality criteria 
items out of a possible 17 (mean (SD): 11 (2)). All studies used the appropriate measurements 
to conduct assessment on appetite-related hormone concentrations. This included ELISA, RIA 
and standard chemiluminescent immunometric assays. The majority of studies included 
information regarding attaining ethical approval. However, the majority of studies failed to 
justify the sample size used or provide evidence for a power calculation. Some studies also 
lacked information on sources of recruitment and whether the sample represented the 




each study. Since studies compared the difference between older and younger adults, the 
criteria regarding non-responders were not relevant (supplementary table 26). 
 
INSERT TABLE 2 NEAR HERE 
 
Discussion  
Understanding differences in appetite-related hormones concentrations between older and 
younger adults provides mechanistic insight into the effect of ageing on the appetite-regulatory 
system. This systematic review and meta-analysis revealed higher fasted and postprandial 
circulating concentrations of CCK, insulin and leptin in older adults. We also observed higher 
postprandial concentrations of PYY in older versus younger adults. These findings were 
concomitant with reduced hunger and energy intake in older adults, which accords with the 
anorectic effects of these hormones [6]. Alternatively, there were no clear differences between 
older and younger adults for circulating concentrations of GLP-1, GIP, total ghrelin and 
acylated ghrelin.  The results from the present study suggests even without the presence of 
known metabolic diseases or co-morbidities, older adults experience alterations in appetite 
regulation. 
The increases in CCK observed in the present review supports previous speculation that CCK 
signalling is increased during ageing. Indeed, the anorectic effects from elevated concentrations 
of CCK in the fasted and postprandial state may even be enhanced in older adults due to 
increased sensitivity to the actions of this hormone [21] via CCK1 receptors on the nucleus of 
the solitary tract and vagal signalling [22]. In the postprandial state CCK is released from the 
intestine in response to nutrients in the intestinal lumen and appears to be, at least partly, 




vagal nerve, increased circulating CCK also delays the rate of gastric emptying which is 
commonly seen in older adults. It has been suggested that delays in gastric emptying in older 
adults could reflect increased small intestinal feedback as a result of increased sensitivity and/or 
exposure of small intestine receptors to CCK [24]. Elevated postprandial concentrations and 
signalling of CCK may play a further role in enhanced satiation in combination with reductions 
in the gastric emptying rates of older adults. 
The most robust differences between older and younger adults in the current review were 
observed for circulating concentrations of leptin, which were higher in older adults in both the 
fasted and postprandial state, with a large and moderate effect size, respectively. Leptin is an 
anorectic hormone secreted by adipose tissue [25] and therefore circulates in proportion to 
body fat stores as a tonic regulator of energy balance [26].  Consequently, the higher levels of 
leptin in older adults may be due to greater adiposity. However, adiposity is unlikely to be the 
sole mechanism for these elevations in leptin as Zamboni et al. [27] demonstrated that after the 
adjustment for body mass, fasted levels of plasma leptin increased with age in a population of 
older women aged 67-78 years. It remains unclear whether older adults experience leptin 
resistance in association with increased circulating concentrations, as experienced by obese 
populations [28]. Consequently, understanding leptin sensitivity in older adults is important to 
appreciate whether elevated concentrations of this hormone exert an anorectic effect and 
whether leptin represents a therapeutic target for improving appetite outcomes in this 
population.  
In accordance with the higher levels of leptin in older adults, fasted and postprandial insulin 
concentrations were also elevated. Circulating levels of insulin are determined primarily by 
peripheral insulin sensitivity [29] which alongside leptin correlate with adiposity [30] and 
deliver information on peripheral energy stores to the central nervous system. Although the 




effects by acting on the arcuate nucleus of the hypothalamus to signal satiety and reduce food 
intake [31]. The observed increases in insulin may therefore contribute towards the attenuation 
of hunger in older adults observed in this review.  However, as with leptin, insulin resistance 
of the hypothalamus may occur in older adults [32], thereby hindering the anorectic effects of 
this peptide. The relative importance of ageing and altered body composition as mediators of 
the increased insulin concentrations is unclear. The mean BMI value for young (23.6 kg·m-2) 
and older adults (24.8 kg·m-2) were similar, suggesting that differences observed in insulin 
concentration are not a result of differences in weight-status (as a proxy of body composition). 
In addition, despite differences in fasted insulin concentrations between older and younger 
adults, mean fasted plasma glucose concentrations were similar at 5.3 mmol·L-1 and 5.0 
mmol·L-1, respectively, and suggested a healthy glucose tolerance in both groups. Additionally, 
mean HOMA-IR values for participants in the included studies were 1.67 for older adults and 
1.57 for younger adults. Regardless, these findings highlight the need for interventions to 
reduce circulating concentrations of insulin from both an appetite and metabolic health 
perspective.  
The PYY findings from this meta-analysis demonstrated a strong trend towards statistical 
significance for higher postprandial concentrations in older versus younger adults. This effect 
was observed despite the inclusion of only four studies and the subsequent likelihood of the 
analysis being underpowered. Interestingly, out of the four included studies in the present 
review, Moss [33]  and Di Francesco et al. [34] both showed significantly higher circulating 
concentrations of PYY in older adults following the ingestion of a test meal. However, 
following intraduodenal infusion of lipid and glucose [35] and  whey-protein [36], circulating 
postprandial PYY concentrations were comparable between younger and older adults. 
Consequently, the effects of age on PYY concentrations appear to be most prominent when 




directly reaching the distal gastrointestinal tract [37].  It is possible that the observed results in 
the present review support previous speculations that bypassing of the stomach during 
intraduodenal infusion may attenuate PYY release, thereby diminishing any potential appetite-
regulatory effects [7]. Critically, the ingestion of food as standardised test-meals reflects typical 
human eating behaviours which suggests that increased PYY concentrations are likely to be 
experienced by older adults in response to habitual feeding. Unlike leptin and insulin, obesity 
does not seem to cause a peripheral resistance to PYY [38-40], suggesting that the observed 
increases in older adults are likely to exert anorectic effects. The increased circulating PYY 
concentrations may further promote satiety by also contributing to reductions in gastric 
emptying rates in older adults [24]. 
Surprisingly, acylated ghrelin, total ghrelin, GLP-1 and GIP concentrations were not 
significantly different between older and younger adults in the present review. Alternatively, 
the differences in leptin, CCK, PYY and insulin appear to align with the reductions in hunger 
and energy intake in older adults observed in this meta-analysis. Consequently, it seems most 
beneficial for future interventions to target CCK, leptin, PYY and insulin when investigating 
methods to augment energy intake to reduce the anorexia of ageing from an endocrine 
perspective. 
As part of the present review, we extracted and analysed data for hunger perceptions and energy 
intake when measured alongside appetite-related hormones in the included studies. These 
findings mirror those of the recent meta-analysis by Giezenaar et al. [41] by demonstrating that 
energy intake was significantly lower in older adults than younger adults. However, in the 
present review, energy intake appeared to be moderated by the method of dietary assessment. 
Specifically, the results revealed that a difference in energy intake was only observed when 
self-report methods were used and not through researcher-assessed methods. It is apparent 




methods to assess energy intake. Therefore, our findings should be considered with caution as 
it is clear that limitations are present in self-report methods [42]. Nonetheless the results 
indicate large decreases in fasted hunger in older adults compared with younger adults which 
is a known predictor for energy intake [43]. Postprandial hunger perceptions also tended to be 
lower in older adults than younger adults but with only a small effect size. In combination with 
differences in appetite-related hormone concentrations, these effects may also be mediated by 
diminished homeostatic regulation of physiological functions in older adults. For example, 
older adults have been shown to experience delayed gastric emptying rate, altered pyloric 
motility and increased antral area [44,45,35,34].  
In the current review, the hormones investigated which aligned with observed reductions in 
hunger and energy intake in older adults were CCK, leptin, insulin and PYY. It must be stressed 
that hormones involved in appetite regulation are only one aspect of a complex system that 
regulates feeding behaviour and that there may be other factors interacting which could also 
contribute to the changes in hunger and energy intake observed. Nevertheless, interventions to 
reduce circulating concentrations of these anorectic hormones may be useful to oppose the 
anorexia of ageing.  
Despite the important findings in the current meta-analysis, some notable limitations must be 
acknowledged. First the hormones PP, oxyntomodulin and fasted acylated ghrelin are known 
to be mediators of appetite regulation. However, these hormones could not be included in the 
analysis due to only one study meeting the criteria for fasted acylated ghrelin and the absence 
of any studies measuring oxyntomodulin or PP concentrations. The present study explored 
differences in appetite regulation in healthy older adults, and it is therefore appreciated that the 
findings cannot be generalised to older adults who possess underlying co-morbidities. It must 
also be noted that the presence of co-morbidities and of the taking of medication amongst 




certain that all participants were free of underlying co-morbidities and were not taking 
medication. Additionally, despite our extensive search retrieving 3103 records, we cannot 
guarantee that our search was completely exhaustive of the relevant literature. However, having 
hand searched the reference lists of all included studies and review articles we are confident 
that we have included all available relevant studies.  
Conclusions 
This meta-analysis reveals that circulating concentrations of insulin, leptin, CCK and PYY are 
increased in older adults. Given the anorectic effect of these appetite-related hormones, such 
changes in older adults provide an underlying mechanism which may contribute towards the 
anorexia of ageing. Interventions to reduce circulating levels of these hormones may be 
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Table 1. Summary of moderator variable analysis for energy intake, GLP-1 and insulin by 
subgroup. 
Moderator Variable p value Comparison 
Hormone Analytical Method 
Fasted Insulin 0.985 RIA (n = 10; SMD 0.26, 95% CI -0.03 to 0.55) 
ELISA (n =7; SMD 0.22, 95% CI -0.35 to 0.80) 
Postprandial Insulin 0.438 RIA (n = 7; SMD 0.34, 95% CI 0.07 to 0.60) 
ELISA (n = 7; SMD 0.06, 95% CI -0.19 to 0.31) 
   
Type of feeding  
Postprandial Insulin 0.427 Infusion (n = 3; SMD 0.01, 95% CI -0.41 to 0.44)  
Feeding (n = 14; SMD 0.20, 95% CI 0.03 to 0.37) 
Postprandial GLP-1  
 
0.296 Feeding (n = 3; SMD 0.30; 95% CI -0.12 to 0.73) 
Infusion (n = 4; SMD -0.01, 95% CI -0.41 to 0.39) 
   
Energy intake assessment method 
 0.015 Researcher measured (n = 7; SMD -0.10, 95% CI -0.88 to 0.68) 





Table 2. Criteria for quality assessment and number (%) of studies scoring points for each criterion 
 
 Studies fulfilling the criteria 
 n (%) 
  Yes No Don’t 
Know 
Criteria    
1 Were the aims/objectives of the study clear? 21 (52.5) 19 (47.5) 0 (0.0) 
Methods    
2 Was the study design appropriate for the stated aim(s)? 34 (85.0) 5 (12.5) 1 (2.5) 
3 Was the sample size justified? 4 (10.0) 36 (90.0) 0 (0.0) 
4 Was the target/reference population clearly defined? (Is it clear who the research was about?) 26 (65.0) 12 (30.0) 2 (5.0) 
5 Was the sample frame taken from an appropriate population base so that it closely represented the target/reference 
population under investigation? 
12 (30.0) 3 (7.5) 25 (62.5) 
6 Was the selection process likely to select subjects/participants that were representative of the target/reference 
population under investigation? 
9 (22.5) 5 (5.0) 26 (65.0) 
7 Were measures undertaken to address and categorise non-responders? - - - 
8 Were the risk factor and outcome variables measured appropriate to the aims of the study?  37 (92.5) 3 (7.5) 0 (0.0) 
9 Were the risk factor and outcome variables measured correctly using instruments/measurements that had been 
trialled, piloted or published previously?  
40 
(100.0) 
0 (0.0) 0 (0.0) 
10 Is it clear what was used to determined statistical significance and/or precision estimates? (e.g. p-values, 
confidence intervals)  
27 (67.5) 
 





11 Were the methods (including statistical methods) sufficiently described to enable them to be repeated?  20 (50.0) 20 (50.0) 0 (0.0) 
Results    
12 Were the basic data adequately described?  23 (57.5) 17 (42.5) 0 (0.0) 
13 Does the response rate raise concerns about non-response bias?  - - - 
14 If appropriate, was information about non-responders described?  - - - 
15 Were the results internally consistent?  32 (80.0) 7 (17.5) 1 (2.5) 
16 Were the results presented for all the analyses described in the methods?  30 (75.0) 10 (25.0) 0 (0.0) 
Discussion    
17 Were the authors' discussions and conclusions justified by the results?  29 (72.5) 11 (27.5) 0 (0.0) 
18 Were the limitations of the study discussed?  21 (52.5) 19 (47.5) 0 (0.0) 
Other    
19 Were there any funding sources or conflicts of interest that may affect the authors’ interpretation of the results?  27 (67.5) 3 (7.5) 10 (25.0) 





Fig 1. Forest plot of standardised mean differences (means ± 95% confidence intervals [CIs] 1 
for studies evaluating the differences in fasted CCK concentrations (a) and postprandial CCK 2 
concentrations (b) in older versus younger adults. The size of each square represents the 3 
relative weight of each comparison. The diamond represents the SMD (mean ± 95% CI) for 4 





Fig 2. Forest plot of standardised mean differences (means ± 95% confidence intervals [CIs] 7 
for studies evaluating the differences in fasted leptin concentrations (a) and postprandial 8 
leptin concentrations (b) in older versus younger adults. The size of each square represents 9 
the relative weight of each comparison. The diamond represents the SMD (mean ± 95% CI) 10 
for the model. 11 
 12 
Fig 3. Forest plot of standardised mean differences (means ± 95% confidence intervals [CIs] 13 
for studies evaluating the differences in fasted insulin concentrations (a) and postprandial 14 
insulin concentrations (b) in older versus younger adults. The size of each square represents 15 
the relative weight of each comparison. The diamond represents the SMD (mean ± 95% CI) 16 





Fig 4. Forest plot of standardised mean differences (means ± 95% confidence intervals [CIs] 19 
for studies evaluating the differences in fasted PYY concentrations (a) and postprandial PYY 20 
concentrations (b) in older versus younger adults. The size of each square represents the 21 
relative weight of each comparison. The diamond represents the SMD (mean ± 95% CI) for 22 





Fig 5. Forest plot of standardised mean differences (means ± 95% confidence intervals [CIs] 25 
for studies evaluating the differences in energy intake in older versus younger adults. The 26 
size of each square represents the relative weight of each comparison. The diamond 27 
represents the SMD (mean ± 95% CI) for the model. 28 
 29 
Fig 6. Forest plot of standardised mean differences (means ± 95% confidence intervals [CIs] 30 
for studies evaluating the differences in fasted hunger (a) and postprandial hunger (b) in older 31 
versus younger adults. The size of each square represents the relative weight of each 32 
comparison. The diamond represents the SMD (mean ± 95% CI) for the model. 33 
Article Title: Differences in circulating appetite-related hormone concentrations between 34 
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Author Names: Kelsie Olivia Johnson, Oliver Michael Shannon, Jamie Matu, Adrian 37 
Holliday, Theocharis Ispoglou, Kevin Deighton 38 
Corresponding Author: Kelsie Johnson, Institute for Sport, Physical Activity and Leisure, 39 
Leeds Beckett University, Leeds, LS6 3QS, United Kingdom (email: 40 
kelsie.johnson@leedsbeckett.ac.uk) 41 
 42 
Supplementary Figure 1. Flowchart of study selection. CCK: cholecystokinin; PP: 43 
pancreatic polypeptide; GLP-1: glucagon-like-peptide 1; GIP: gastric inhibitory peptide; 44 
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Supplementary Figure 2. Forest plot of standardised mean differences (means ± 95% 67 
confidence intervals [CIs]) for studies evaluating postprandial acylated ghrelin 68 
concentrations in older versus younger adults. The size of each square represents the 69 
relative weight of each comparison. The diamond represents the standardised mean 70 
difference (mean ± 95% CI) for the model.  71 
 72 
Supplementary Figure 3. Forest plot of standardised mean differences (means ± 95% 73 
confidence intervals [CIs]) for studies evaluating fasted total ghrelin concentrations (A) and 74 




square represents the relative weight of each comparison. The diamond represents the 76 
standardised mean difference (mean ± 95% CI) for the model. 77 
 78 
Supplementary Figure 4. Forest plot of standardised mean differences (means ± 95% 79 
confidence intervals [CIs]) for studies evaluating fasting GLP-1 concentrations (A) and (B) 80 
postprandial GLP-1 concentrations in older versus younger adults. The size of each square 81 
represents the relative weight of each comparison. The diamond represents the standardised 82 
mean difference (mean ± 95% CI) for the model. 83 
 84 
Supplementary Figure 5. Forest plot of standardised mean differences (means ± 95% 85 
confidence intervals [CIs]) for studies evaluating fasting GIP concentrations (A) and 86 




represents the relative weight of each comparison. The diamond represents the standardised 88 
mean difference (mean ± 95% CI) for the model. 89 
Supplementary Material 1 90 
Search Strategy 91 
The following terms were searched for in titles/abstracts of each database, with MeSH terms 92 
utilised where appropriate. 93 
1. older people 94 
2. older persons 95 
3. older person 96 
4. older individuals 97 
5. older individual 98 
6. older adults 99 
7. older adult 100 
8. aged  101 
9. aged [MeSH Terms] 102 
10. elderly 103 
11. aging [MeSH Terms] 104 
12. aging  105 
13. ageing 106 
 107 
14. appetite hormones 108 
15. appetite hormone 109 
16. appetite-related hormones 110 
17. appetite-related hormone 111 
18. appetite-regulating hormones 112 
19. appetite-regulating hormone 113 
20. gastrointestinal hormones 114 
21. gastrointestinal hormone 115 
22. GI hormones 116 
23. GI hormone 117 
24. Cholecystokinin 118 
25. Cholecystokinin [MeSH Terms] 119 
26. CCK 120 
27. Peptide YY 121 
28. PYY 122 
29. Glucagon-like-peptide-1 123 
30. Glucagon like peptide 1 124 
31. Glucagon-like peptide 1 [MeSH Terms] 125 
32. Glucagon-like peptide 1 126 
33. Glucagon-like peptide 1 127 
34. Glucagon-like-peptide 1 128 
35. Glp 1 129 




37. Leptin 131 
38. Leptin [MeSH Terms] 132 
39. Ghrelin 133 
40. Ghrelin [MeSH Terms] 134 
41. Pancreatic polypeptide 135 
42. Gastric inhibitory peptide 136 
43. Gastric-inhibitory-peptide 137 
44. GIP 138 
45. Oxyntomodulin 139 
46. Oxyntomodulin [MeSH Terms] 140 
47. OXM 141 
48. Insulin 142 
49. Insulin [MeSH Terms] 143 
 144 
50. appetite 145 
51. appetite [MeSH Terms] 146 
52. hunger 147 
53. hunger [MeSH Terms] 148 
54. fullness 149 
55. satiation  150 
56. satiation [MeSH Terms] 151 
57. satiety 152 
58. desire to eat  153 
59. prospective food consumption 154 
 155 
60. energy intake  156 
61. food intake 157 
62. dietary intake 158 
63. animals 159 
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Ghrelin 
Ghrelin [MeSH Terms] 
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Oxyntomodulin [MeSH Terms] 
OXM 
Insulin 
Insulin [MeSH Terms] 
 
appetite 
appetite [MeSH Terms] 
hunger 
hunger [MeSH Terms] 
fullness 
satiation  
satiation [MeSH Terms] 
satiety 

















I. older people or older persons or older person or older individuals or older individual 175 
or older adults or older adult or aged[ MeSH Terms] or elderly or aging[MeSH 176 




II. appetite hormones or appetite hormone or appetite-related hormones or appetite-181 
related hormone or appetite-regulating hormones or appetite-regulating hormone or 182 
gastrointestinal hormones or gastrointestinal hormone or GI hormones or GI hormone 183 
or Cholecystokinin or Cholecystokinin [MeSH Terms] or CCK or Peptide YY or PYY 184 
or Glucagon-like-peptide-1 or Glucagon like peptide 1 or Glucagon-like peptide 1 185 
[MeSH Terms] or Glucagon-like peptide 1 or Glucagon-like peptide 1 or Glucagon-186 
like-peptide 1 or Glp 1 or Glp-1 or Leptin or Leptin [MeSH Terms] or Ghrelin or 187 
Ghrelin [MeSH Terms] or Pancreatic polypeptide or Gastric inhibitory peptide or 188 
Gastric-inhibitory-peptide or GIP or Oxyntomodulin or Oxyntomodulin [MeSH 189 




III. appetite or appetite [MeSH Terms] or hunger or hunger [MeSH Terms] or fullness or 194 
satiation or satiation [MeSH Terms] or satiety or desire to eat or prospective food 195 
consumption 196 
 197 
OR  198 
 199 




animals [MeSH Terms] NOT humans 204 
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